在侵袭性乳腺癌患者中,瘤芽与新发现和其他已确定的预后参数的相关性
Neha D Borde1, Yash M Thesiya, Meera S Mahajan
1Department of Pathology, MGM Medical College and Hospital, Aurangabad, Maharashtra, India.
Indian journal of pathology & microbiology
|October 18, 2024
概括
乳腺癌中的高瘤芽与较大的瘤大小,扩散和较低的免疫反应有关. 这一发现表明,瘤芽得分可以作为乳腺癌患者的宝贵预后指标.
科学领域:
- 在瘤学瘤学.
- 病理学 病理学 病理学
背景情况:
- 乳腺癌是女性的主要恶性瘤.
- 确定的预后标志物包括瘤大小,等级,结节状况和激素受体状况.
研究的目的:
- 为了将外周瘤芽 (pTB) 与瘤透淋巴细胞 (sTILs) 相关联.
- 评估pTB与侵袭性乳腺癌中确定的预后因素之间的关系.
主要方法:
- 100例侵袭性乳腺癌病例的回顾性多中心研究.
- 评估周围瘤芽 (pTB) 和瘤透淋巴细胞 (sTILs) 的评估.
- 肺结核与瘤大小,淋巴血管侵袭,围神经侵袭,瘤阶段 (pT,pN) 和sTILs的相关性.
主要成果:
- 在34例病例中观察到高瘤芽 (>20个芽/10 hpf).
- 在高瘤芽和更大的瘤大小,淋巴血管入侵,围神经入侵,晚期瘤阶段 (pT,pN) 和低STILs之间发现了显著的关联.
- 高瘤芽和年龄,组织学类型,瘤等级,DCIS,ER,PR或HER2Neu状态之间没有显著的关联.
结论:
- 周围瘤的芽是侵袭性乳腺癌的显著预后指标.
- 瘤芽得分可以用作乳腺癌的预后标志物.
更多相关视频
11:12Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material
Published on: August 1, 2018
8.0K
07:47Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
1.4K
相关概念视频
Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Cancer Survival Analysis
328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328
